Rose Diagnostics
Carlsbad, US · Founded 2023 · Delaware corporation
Find your way into Rose Diagnostics
Sign up to see every warm intro you have to Rose Diagnostics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Rose Diagnostics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
AV
Adolfo VelazquezNamed on SEC filing
DP
Donna PadavanNamed on SEC filing
AM
Andrew MorrisNamed on SEC filing
EB
Eric BrouwerNamed on SEC filing
Board
PG
Paul GoldBoard director
Reported raises · per SEC filings
Form D private placements$5.6M disclosed across 3 rounds · 2024–2026
▶$2.2MraisedSep 2026 · 18 investors · Other Health CareRule 506(b)
▶$2.2MraisedSep 2026 · 18 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Andrew MorrisExecutive Officer, Director
- Eric BrouwerExecutive Officer, Director
- Adolfo VelazquezExecutive Officer, Director
- Donna PadavanExecutive Officer, Director
- Paul GoldDirector
- Offering amount
- $3M
- Amount sold
- $2.2M
- Minimum investment
- $5K
- First sale
- Jul 2026
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
▶$2.3MraisedMay 2025 · 18 investors · Other Health CareRule 506(b)
▶$2.3MraisedMay 2025 · 18 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Adolfo VelazquezExecutive Officer, Director
- Donna PadavanExecutive Officer, Director
- Andrew MorrisExecutive Officer, Director
- Eric BrouwerExecutive Officer, Director
- Paul GoldDirector
- Offering amount
- $3M
- Amount sold
- $2.3M
- Minimum investment
- $5K
- First sale
- May 2025
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
▶$1MraisedJun 2024 · 13 investors · Other TechnologyRule 506(b)
▶$1MraisedJun 2024 · 13 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Adolfo VelazquezExecutive Officer, Director
- Paul GoldDirector
- Eric BrouwerExecutive Officer, Director
- Donna PadavanExecutive Officer, Director
- Andrew MorrisExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $1M
- First sale
- Jun 2024
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Rose Diagnostics raised?
- Rose Diagnostics has disclosed $5.6M raised across 3 rounds.
- Where is Rose Diagnostics headquartered?
- Rose Diagnostics is headquartered in Carlsbad, US.